Home World News U.S. drug company Merck to share license for experimental covid-19 treatment with nonprofit organization

U.S. drug company Merck to share license for experimental covid-19 treatment with nonprofit organization

0
U.S. drug company Merck to share license for experimental covid-19 treatment with nonprofit organization

[ad_1]

“At long last, the first public health license for a covid-19 treatment or vaccine has been signed, allowing this medicine to be produced by all capable producers, which will increase supply and drive down prices,” said Mohga Kamal-Yanni, senior health policy adviser to the People’s Vaccine Alliance, a coalition advocating rapid production and equitable deployment of covid drugs.

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here